Nordson
349 of 416 with a diagram, by size
Q3 FY26 May 1 – Jul 31, 2026
The numbers behind the diagram
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.82 | 100% | +10% |
| Industrial precision | 0.35 | 43% | +0% |
| Medical & fluid | 0.21 | 26% | −3% |
| Advanced technology | 0.18 | 22% | +4% |
| Other | 0.08 | 9% | |
| Cost of revenue | −0.36 | 44% | |
| Gross profit | 0.45 | 55% margin | +1pp |
| SG&A | −0.23 | 28% | +0pp |
| Operating profit | 0.22 | 27% margin | +2pp |
| Interest & other costs | −0.04 | ||
| Tax | −0.03 | ||
| Net profit | 0.15 | 19% margin | +2pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.74 | 100% | +8% |
| Industrial precisions | 0.35 | 47% | |
| Medical fluid systems | 0.21 | 29% | |
| Advanced technology systems | 0.18 | 24% | |
| Cost of revenue | −0.34 | 45% | |
| Gross profit | 0.40 | 55% margin | +0pp |
| SG&A | −0.21 | 28% | −2pp |
| Operating profit | 0.20 | 27% margin | +2pp |
| Interest & other costs | −0.06 | ||
| Tax | −0.02 | ||
| Net profit | 0.12 | 16% margin | −1pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.67 | 100% | +9% |
| Industrial precisions | 0.33 | 49% | +9% |
| Medical fluid systems | 0.19 | 29% | +0% |
| Advanced technology systems | 0.15 | 22% | +23% |
| Cost of revenue | −0.30 | 45% | |
| Gross profit | 0.37 | 55% margin | +0pp |
| SG&A | −0.20 | 30% | −2pp |
| Operating profit | 0.17 | 25% margin | +2pp |
| Tax | −0.03 | ||
| Net profit | 0.13 | 20% margin | +5pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.75 | 100% | +1% |
| Cost of revenue | −0.33 | 44% | |
| Gross profit | 0.42 | 56% margin | +2pp |
| SG&A | −0.21 | 28% | −2pp |
| Operating profit | 0.21 | 28% margin | +4pp |
| Interest & other costs | −0.03 | ||
| Tax | −0.03 | ||
| Net profit | 0.15 | 20% margin | +4pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.74 | 100% | +12% |
| Industrial precision | 0.35 | 47% | +1% |
| Medical & fluid | 0.22 | 30% | +32% |
| Advanced technology | 0.17 | 23% | +17% |
| Cost of revenue | −0.34 | 45% | |
| Gross profit | 0.41 | 55% margin | −1pp |
| SG&A | −0.21 | 28% | −3pp |
| Other | −0.01 | 2% | +0pp |
| Operating profit | 0.19 | 25% margin | +0pp |
| Interest & other costs | −0.03 | ||
| Tax | −0.03 | ||
| Net profit | 0.13 | 17% margin | −1pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.68 | 100% | +5% |
| Industrial precision | 0.32 | 47% | −8% |
| Medical & fluid | 0.20 | 30% | +20% |
| Advanced technology | 0.16 | 23% | +18% |
| Cost of revenue | −0.31 | 45% | |
| Gross profit | 0.37 | 55% margin | −1pp |
| SG&A | −0.21 | 30% | +0pp |
| Operating profit | 0.17 | 25% margin | −1pp |
| Interest & other costs | −0.03 | ||
| Tax | −0.03 | ||
| Net profit | 0.11 | 16% margin | −2pp |
Financial health
The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.
The balance sheet, capital flow, debt schedule and capital structure open with a free account.
Quarter by quarter
Every set of results we hold, newest first. Open one on its own page. The arrow beside a quarter shows it in the diagram above.
| Quarter | Period | Reported | Revenue | Year over year | Operating margin | Net profit | Net margin |
|---|---|---|---|---|---|---|---|
| Q3 FY26 May 1 – Jul 31, 2026 reported Aug 20, 2026 Operating margin 27% Net profit $0.15B | May 1 – Jul 31, 2026 | Aug 20, 2026 | $0.82B | +10% | 27% | $0.15B | 19% |
| Q2 FY26 Feb 1 – Apr 30, 2026 reported May 21, 2026 Operating margin 27% Net profit $0.12B | Feb 1 – Apr 30, 2026 | May 21, 2026 | $0.74B | +8% | 27% | $0.12B | 16% |
| Q1 FY26 Nov 1, 2025 – Jan 31, 2026 reported Feb 19, 2026 Operating margin 25% Net profit $0.13B | Nov 1, 2025 – Jan 31, 2026 | Feb 19, 2026 | $0.67B | +9% | 25% | $0.13B | 20% |
| Q4 FY25 Aug 1 – Oct 31, 2025 reported Dec 17, 2025 Operating margin 28% Net profit $0.15B | Aug 1 – Oct 31, 2025 | Dec 17, 2025 | $0.75B | +1% | 28% | $0.15B | 20% |
| Q3 FY25 May 1 – Jul 31, 2025 reported Aug 21, 2025 Operating margin 25% Net profit $0.13B | May 1 – Jul 31, 2025 | Aug 21, 2025 | $0.74B | +12% | 25% | $0.13B | 17% |
| Q2 FY25 Feb 1 – Apr 30, 2025 reported May 29, 2025 Operating margin 25% Net profit $0.11B | Feb 1 – Apr 30, 2025 | May 29, 2025 | $0.68B | +5% | 25% | $0.11B | 16% |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest